Fragile biotherapeutics-including therapeutic proteins, peptides, antibody fragments, nucleic acids, and extracellular-vesicle therapeutics-are increasingly central to precision medicine, yet their delivery is limited by conformational instability, enzymatic degradation, oxidative damage, interfacial adsorption, and po...
Kai-Lang Mu, Rui-qi Liao, Jun-Li Xie et al.· International Journal of Bio...· 0 citations
The mechanistic basis, pharmacological rationale, and translational challenges of targeting the extracellular cGAMP-ENPP1 axis in cancer are summarized and a biomarker-guided framework incorporating cGAMP-generating capacity, ENPP1 expression and enzymatic activity, STING-response competence, and on-treatment pharmacod...
Kailang Mu, Rui-qi Liao, Jun Xie et al.· European Journal of Pharmaco...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.